SCHEMBL25755193

SCHEMBL25755193

Cc1ccc2c3ccccc3c3cc(-c4cccc(-c5nc6cc(-c7nc(-c8ccccc8)nc(-c8ccccc8)n7)ccc6s5)c4)ccc3c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 7/20 0.49
▸ MAPT P10636 7/20 0.49
▸ TP53 P04637 2/20 0.49
▸ RAB9A P51151 9/20 0.42
▸ NFKB1 P19838 8/20 0.42
▸ NFKB2 Q00653 8/20 0.42
▸ RELA Q04206 8/20 0.42
▸ NPC1 O15118 7/20 0.42
▸ HPGD P15428 2/20 0.42
▸ STAT1 P42224 1/20 0.42
▸ KDM4E B2RXH2 5/20 0.41
▸ PKM P14618 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ GAA P10253 3/20 0.41
▸ GLA P06280 2/20 0.41
▸ APP P05067 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ TDP1 Q9NUW8 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25459568 0.93 KDM4E (0.46) SMN1; SMN2MAPTTP53RAB9ANFKB1
SCHEMBL25459565 0.87 RAB9A (0.48) SMN1; SMN2MAPTTP53RAB9ANFKB1
SCHEMBL25459747 0.83 APP (0.51) SMN1; SMN2MAPTTP53RAB9ANFKB1
SCHEMBL27049208 0.83 RAB9A (0.54) SMN1; SMN2MAPTTP53RAB9ANFKB1
SCHEMBL16641506 0.83 L3MBTL1 (0.47) SMN1; SMN2MAPTRAB9ANFKB1NFKB2
SCHEMBL21137707 0.83 L3MBTL1 (0.47) SMN1; SMN2MAPTRAB9ANFKB1NFKB2
SCHEMBL27049229 0.82 RAB9A (0.53) SMN1; SMN2MAPTTP53RAB9ANFKB1
SCHEMBL25755286 0.81 KDM4E (0.37) SMN1; SMN2MAPTTP53RAB9ANFKB1
SCHEMBL16641428 0.80 L3MBTL1 (0.50) SMN1; SMN2MAPTTP53RAB9ANFKB1
SCHEMBL20243220 0.79 CYP1A1 (0.48) SMN1; SMN2MAPTTP53RAB9ANFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX SMN1; SMN2 4240/4885MAPT 768/4885TP53 4175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback